Search
CONTACT US

DISCOVER THE POWER OF CONNECTED CHRONIC CARE

Optimize care, cost, and utilization for multiple chronic conditions and comorbidities with an AI-driven digital health platform.

TAILORED TO INDIVIDUALS. SCALABLE TO POPULATIONS.

individuals image 1

Put members in control of their health and promote positive behaviors with personalized digital coaching.

individuals image 2

Take a data-driven approach to care management to equip care managers with real-time, actionable insights on health status.

individuals image 3

Optimize chronic care programs with a universal experience across multiple cardiometabolic conditions.

DIGITAL HEALTH AIMED AT MEMBER CARE

cost savings

AVERAGE COST SAVINGS

$3048 - $3252 per
person with type 2
diabetes, annually 1

reduction

A1C REDUCTION

A 1.2 to 2.0-point mean
A1C reduction in
individuals living with
type 2 diabetes 2,3

net promoter

NET PROMOTER

70.1 NPS score +10 higher
satisfaction scores than the
leading competition

Additional Resources

postDefaultImage

Featured Story: Health Plan Opportunities to Control Costs Related to Chronic Disease

See how to break down care access barriers and help people self-manage their chronic conditions.
postDefaultImage

A Welldoc Overview: The Right Fit for Your Care Model

Find out why Welldoc is the right fit for your care model.
postDefaultImage

Whitepaper: Digital Health: Now and Next

Learn how to navigate a disrupted chronic care landscape with clear, actionable, evidence-based strategies.

Learn how Welldoc can help you impact outcomes

VISIT SITE
References:

1 IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
2 Tang PY, Duni J, Peeples MM, et al. Complementarity of digital health and peer support: “This Is What’s Coming.” Front Clin Diabetes Health. 2021;2. doi:10.3389/fcdhc.2021.646963
3 Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention for Glycemic Control. Journal of Diabetes Science and Technology. 2014;8(2):362-370. doi:10.1177/1932296813514503

Welldoc's BlueStar® may be covered under one or more of the following United States Patents: 8,838,513; 9,064,040; 9,536,053; 9,754,077; 9,824,190; 9,858,394; 9,881,136; 10,152,675; 10,176,893; 10,192,638; 10,672,509; 10,748,658; 10,818,389; 10,839,951; 10,846,607; 10,854,337; 10,860,943; 10,872,686; 10,937,535; 10,978,207; 11,004,558; 11,147,480; 11,211,156; 11,298,054; 11,344,232; 11,357,427; 11,361,238; 11,361,854; 11,361,857; 11,521,727; 11,527,314; 11,538,582; 11,544,610; 11,564,600; 11,587,660; 11,587,681; 11,651,845; 11,699,511; 11,735,300; 11,798,670; 11,894,142; 12,009,086 and 12,011,262. This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the America Invents Act and 35 U.S.C. §287(a). Additional patents may be issued or pending in the US and elsewhere.

Privacy Policy | © Welldoc, Inc.

SALES ADVANTAGE
SCHEDULE A MEETING

Who we help

The platform

Resources

Company

Indications

CONTACT US
Back to top
small_c_popup.png

Taking Diabetes Self-Management to the Next Level